Bausch Health Companies
Price & Volume
Stats
See more52W Range | $4.41-$8.69 |
Market Cap | $2B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $10.5B |
Revenue Growth (YoY) | 11.7% |
Gross Profit (12 Mos) | $7.4B |
Diluted EPS | -$3.24 |
News
See moreYahoo Finance • 4 days ago
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
Yahoo Finance • 7 days ago
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by 2032 from $4.7 Billion in 2025 Featuring AbbVie, Aphria, Aurora Cannabis, Bausch Health, and Canopy Growth
Yahoo Finance • 24 days ago
Why Bausch Health Companies Was Crawling Higher This Week
Yahoo Finance • 25 days ago
TSX up 455 Points at Midday With Healthcare, Materials, The Best Performers
About
CEO | Mr. Thomas J. Appio |
CFO | Mr. Jean-Jacques Charhon |
Address | 2150 St. Elzéar Blvd. West, Laval, QC, Canada, H7L 4A8 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 20,300 |